Background illustration for clinical trials search

Paid Clinical Trials Iowa

Discover 657 paid clinical trials in Iowa. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response

for
Breast Neoplasm Female
Location: Madison WI, Iowa City IA
Sponsor: University of Wisconsin, Madison

Sex: Female

Age: 18+

Code: NCT03096418

Recruiting

Oxytocin and Fetal Heart Rate Changes

for
Fetal Bradycardia Complicating Labor and Delivery,
Location: Iowa City IA
Sponsor: Unyime Ituk

Sex: Female

Age: 18 - 55

Code: NCT03232918

Recruiting

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

for
Neuroendocrine Tumors Unresectable,
Location: Baltimore MD, Fairfax VA, Chapel Hill NC, Miami FL,
Sponsor: Perspective Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT05636618

Phase 1, Phase 2, Recruiting

Subthalamic Nucleus Deep Brain Stimulation in Speech Study

for
Parkinson Disease, Dysarthria
Location: Iowa City IA
Sponsor: Jeremy Greenlee

Sex: All

Age: 21 - 70+

Code: NCT05493670

Recruiting

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

for
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma,
Location: New York NY, Richmond VA, Webster NY, Rochester NY,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05890352

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

for
Cystic Fibrosis
Location: Boston MA, Burlington VT, Philadelphia PA, Baltimore MD,
Sponsor: University of Washington, the Collaborative Health Studies Coordinating Center

Sex: All

Age: 3 - 18

Code: NCT06654752

Recruiting

Cochlear Implant Speech in Noise Processing

for
Hearing Loss, Adult-Onset, Speech Intelligibility,
Location: Iowa City IA
Sponsor: Craig D. Workman, PhD

Sex: All

Age: 18 - 70+

Code: NCT06860152

Recruiting

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

for
Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor,
Location: Boston MA, Baltimore MD, Bethesda MD, Toronto,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 12+

Code: NCT04924075

Phase 2, Recruiting

Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

for
Myotonic Dystrophy 1, DM1
Location: Richmond VA, Rochester NY, Gainesville FL, Columbus OH,
Sponsor: Virginia Commonwealth University

Sex: All

Age: 18 - 70

Code: NCT03981575

Recruiting

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

for
Solid Tumor
Location: Providence RI, New York NY, Hackensack NJ, Newark DE,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT05584670

Phase 1, Phase 2, Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Norwich CT, Hackensack NJ, Albany NY, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase 3, Recruiting

Preventing Injured Knees From osteoArthritis: Severity Outcomes

for
Osteoarthritis, Knee, Post-traumatic Osteoarthritis, ACL Tear
Location: Boston MA, New York NY, Chapel Hill NC, Cleveland OH,
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18 - 45

Code: NCT06096259

Phase 2, Recruiting

Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

for
Burns
Location: Washington D.C. DC, Iowa City IA, Phoenix AZ,
Sponsor: Skingenix, Inc.

Sex: All

Age: 18+

Code: NCT01297400

Phase 2, Recruiting

A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

for
Overactive Bladder, Urge Incontinence, Incontinence, Urinary,
Location: New York NY, Hialeah FL, West Columbia SC, Atlanta GA,
Sponsor: Valencia Technologies Corporation

Sex: All

Age: 18+

Code: NCT05685433

Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Sydney, Saint John, Scarborough ME, West Haven CT,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase 3, Recruiting

Interactive Resuscitation Application for Mothers About to Experience Premature Infant Resuscitation

for
Resuscitation
Location: Iowa City IA
Sponsor: Stephanie Stewart

Sex: All

Age: 18 - 60

Code: NCT05243043

Recruiting

Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling

for
HER2-negative Breast Cancer
Location: Newark NJ, Baltimore MD, York PA, Mechanicsville VA,
Sponsor: NSABP Foundation Inc

Sex: Female

Age: 18+

Code: NCT03412643

Phase 2, Recruiting

The ED-AWARENESS-2 Trial

for
Awareness, Mechanical Ventilation, Intubation Complication,
Location: Camden NJ, Iowa City IA, Minneapolis MN, Seattle WA
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT05534243

Recruiting

SPIROMICS Study of Early COPD Progression (SOURCE)

for
COPD, Early-Onset
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: University of Massachusetts, Worcester

Sex: All

Age: 30 - 55

Code: NCT05033990

Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Boston MA, Worcester MA, New Haven CT, Stony Brook NY,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase 1, Recruiting

Popular cities in Iowa

Offering a distinguished healthcare infrastructure and top class research institutions, Iowa has emerged as a significant base for a wide range of clinical trials. Major institutions such as the University of Iowa Hospitals and Clinics and the Holden Comprehensive Cancer Center are at the forefront of these studies, driving advancements in fields like oncology, cardiovascular research, and more. Iowa’s commitment to medical innovation and its growing network of research centers make it a developing hub in cutting-edge clinical trials.

Why choose Iowa for clinical trials?

Iowa offers distinct advantages for those participating in clinical trials. The state's distinct population, combined with its strong agricultural and rural communities, provides a diverse range of participants that enhances the accuracy and applicability of research findings. Iowa is also recognized for its innovative research environment and its cutting-edge medical advancements, driven by leading institutions such as the University of Iowa.

By choosing to participate in a clinical trial in Iowa, participants contribute to critical medical research while benefiting from a well-established and supportive clinical research infrastructure that promotes breakthroughs in patient care and treatment.

Common conditions studied in Iowa

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Iowa